|
|||||
|
|
Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris |
|
| Authors: | Sharifi Mohsen,Fares Wassim,Abdel-Karim Isam,Koch J Michael,Sopko Joseph,Adler Dale Hyperbaric Oxygen Therapy in Percutaneous Coronary Interventions Investigators |
| Affiliation: | a Department of Cardiology, St. Vincent Charity Hospital, Case Western Reserve University and the University Hospitals of Cleveland, Cleveland, Ohio, USA b Texas Tech University Health Sciences Center, Odessa, Texas, USA |
| Abstract: | The purpose of this trial was to assess whether the addition of hyperbaric oxygen to percutaneous coronary intervention can reduce clinical restenosis. Major adverse cardiac events at 8 months were found in only 1 of 24 patients (4%) who received hyperbaric oxygen compared with 13 of 37 patients (35%) who did not. |
| Keywords: | |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |